Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Long-Term Deferred Tax (2022 - 2025)

Jin Medical International (ZJYL) has disclosed Long-Term Deferred Tax for 4 consecutive years, with $141801.0 as the latest value for Q3 2025.

  • Quarterly Long-Term Deferred Tax rose 16.88% to $141801.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $141801.0 through Sep 2025, up 16.88% year-over-year, with the annual reading at $141801.0 for FY2025, 16.88% up from the prior year.
  • Long-Term Deferred Tax hit $141801.0 in Q3 2025 for Jin Medical International, up from $121322.0 in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $245212.0 in Q3 2022 to a low of $121322.0 in Q3 2024.
  • Historically, Long-Term Deferred Tax has averaged $165202.5 across 4 years, with a median of $147138.0 in 2023.
  • Biggest five-year swings in Long-Term Deferred Tax: plummeted 37.82% in 2023 and later increased 16.88% in 2025.
  • Year by year, Long-Term Deferred Tax stood at $245212.0 in 2022, then tumbled by 37.82% to $152475.0 in 2023, then fell by 20.43% to $121322.0 in 2024, then increased by 16.88% to $141801.0 in 2025.
  • Business Quant data shows Long-Term Deferred Tax for ZJYL at $141801.0 in Q3 2025, $121322.0 in Q3 2024, and $152475.0 in Q3 2023.